Salvianolic acid B protects against acute and chronic liver injury by inhibiting Smad2C/L phosphorylation

Tao,Xiang-Ming; Li,Dong; Zhang,Chong; Wen,Guang-Hua; Wu,Chao; Xu,Yuan-Yuan; Kan,Yue; Lu,Wan-Peng; Ding,Han-Yan; Yang,Yan

doi:10.3892/etm.2021.9772

Salvianolic acid B protects against acute and chronic liver injury by inhibiting Smad2C/L phosphorylation

Authors:
- Xiang-Ming Tao
- Dong Li
- Chong Zhang
- Guang-Hua Wen
- Chao Wu
- Yuan-Yuan Xu
- Yue Kan
- Wan-Peng Lu
- Han-Yan Ding
- Yan Yang
View Affiliations

Affiliations: Department of Pharmacology, Anhui Medical University, Key Laboratory of Anti-inflammatory and Immunopharmacology, Ministry of Education, Hefei, Anhui 230032, P.R. China
Published online on: February 10, 2021 https://doi.org/10.3892/etm.2021.9772
Article Number: 341
Copyright: © Tao et al. This is an open access article distributed under the terms of Creative Commons Attribution License.

Metrics: Total Views: 0 (Spandidos Publications: | PMC Statistics: )

Metrics: Total PDF Downloads: 0 (Spandidos Publications: | PMC Statistics: )

Cited By (CrossRef): 0 citations Loading Articles...

Abstract

Salvianolic acid B (Sal B) has strong antioxidant and anti-fibrosis effects, which are related to the transforming growth factor β/Smad signaling pathway. However, how Sal B affects this antioxidant pathway and the phosphorylation (p-) of Smad2 at both the COOH-terminal (pSmad2C) and linker region (pSmad2L) are unknown. The aims of the present study were to investigate the underlying mechanisms of Sal B on acute and chronic liver injury induced by CCl₄ and H₂O₂, and its effects on p-Smad2C/L. In in vivo experiments, acute and chronic liver injury models were induced by CCl₄, and the oxidative damage cell model was established in vitro with H₂O₂. Liver histopathology was assessed using hematoxylin and eosin and Van Gieson's staining. Moreover, serum biochemical indicators were analyzed using specific assay kits. Furthermore, the present study evaluated the oxidant/antioxidant status in acute and chronic liver injury models by oxidative stress parameters such as malondialdehyde, glutathione and superoxide dismutase. In addition, western blot analysis was performed to analyze the protein expression levels of pSmad2C, pSmad2L, nuclear factor erythroid-2-related factor 2 (Nrf2) and heme oxygenase-1 (HO-1). It was found that Sal B improved liver histology, decreased the levels of aminotransferase and attenuated oxidative stress in acute and chronic liver injury models. Additionally, the protein expression levels of pSmad2C and pSmad2L were decreased, but Nrf2 and HO-1 expression levels were increased both in vivo and in vitro. Collectively, the present results suggested that Sal B may protect against acute and chronic liver injury via inhibition of Smad2C/L phosphorylation, and the Nrf2/HO-1 signaling pathway may play an important role in this process.

View Figures

View References

1	Ramadori G, Moriconi F, Malik I and Dudas J: Physiology and pathophysiology of liver inflammation, damage and repair. J Physiol Pharmacol. 59:107–117. 2008.PubMed/NCBI
2	Hernandez-Gea V and Friedman SL: Pathogenesis of liver fibrosis. Annu Rev Pathol. 6:425–456. 2011.PubMed/NCBI View Article : Google Scholar
3	Enomoto M, Morikawa H, Tamori A and Kawada N: Noninvasive assessment of liver fibrosis in patients with chronic hepatitis B. World J Gastroenterol. 20:12031–12038. 2014.PubMed/NCBI View Article : Google Scholar
4	Dewidar B, Meyer C, Dooley S and Meindl-Beinker AN: TGF-β in hepatic stellate cell activation and liver fibrogenesis-Updated 2019. Cells. 8(8)2019.PubMed/NCBI View Article : Google Scholar
5	Xu F, Liu C, Zhou D and Zhang L: TGF-β/SMAD pathway and its regulation in hepatic fibrosis. J Histochem Cytochem. 64:157–167. 2016.PubMed/NCBI View Article : Google Scholar
6	Yoshida K, Murata M, Yamaguchi T, Matsuzaki K and Okazaki K: Reversible human TGF-β signal shifting between tumor suppression and fibro-carcinogenesis: Implications of Smad phospho-isoforms for hepatic epithelial-mesenchymal transitions. J Clin Med. 5(5)2016.PubMed/NCBI View Article : Google Scholar
7	Yoshida K, Murata M, Yamaguchi T and Matsuzaki K: TGF-β/Smad signaling during hepatic fibro-carcinogenesis (review). Int J Oncol. 45:1363–1371. 2014.PubMed/NCBI View Article : Google Scholar
8	Matsuzaki K: Smad phosphoisoform signals in acute and chronic liver injury: Similarities and differences between epithelial and mesenchymal cells. Cell Tissue Res. 347:225–243. 2012.PubMed/NCBI View Article : Google Scholar
9	Arfmann-Knübel S, Struck B, Genrich G, Helm O, Sipos B, Sebens S and Schäfer H: The crosstalk between Nrf2 and TGF-β1 in the epithelial-mesenchymal transition of pancreatic duct epithelial cells. PLoS One. 10(e0132978)2015.PubMed/NCBI View Article : Google Scholar
10	Choi HK, Pokharel YR, Lim SC, Han HK, Ryu CS, Kim SK, Kwak MK and Kang KW: Inhibition of liver fibrosis by solubilized coenzyme Q10: Role of Nrf2 activation in inhibiting transforming growth factor-beta1 expression. Toxicol Appl Pharmacol. 240:377–384. 2009.PubMed/NCBI View Article : Google Scholar
11	Okita Y, Kamoshida A, Suzuki H, Itoh K, Motohashi H, Igarashi K, Yamamoto M, Ogami T, Koinuma D and Kato M: Transforming growth factor-β induces transcription factors MafK and Bach1 to suppress expression of the heme oxygenase-1 gene. J Biol Chem. 288:20658–20667. 2013.PubMed/NCBI View Article : Google Scholar
12	Michaeloudes C, Chang PJ, Petrou M and Chung KF: Transforming growth factor-β and nuclear factor E2–related factor 2 regulate antioxidant responses in airway smooth muscle cells: Role in asthma. Am J Respir Crit Care Med. 184:894–903. 2011.PubMed/NCBI View Article : Google Scholar
13	Cao W, Guo XW, Zheng HZ, Li DP, Jia GB and Wang J: Current progress of research on pharmacologic actions of salvianolic acid B. Chin J Integr Med. 18:316–320. 2012.PubMed/NCBI View Article : Google Scholar
14	Lin YL, Wu CH, Luo MH, Huang YJ, Wang CN, Shiao MS and Huang YT: In vitro protective effects of salvianolic acid B on primary hepatocytes and hepatic stellate cells. J Ethnopharmacol. 105:215–222. 2006.PubMed/NCBI View Article : Google Scholar
15	Tao YY, Wang QL, Shen L, Fu WW and Liu CH: Salvianolic acid B inhibits hepatic stellate cell activation through transforming growth factor beta-1 signal transduction pathway in vivo and in vitro. Exp Biol Med (Maywood). 238:1284–1296. 2013.PubMed/NCBI View Article : Google Scholar
16	Ying M, Meng F, Chao W, et al: Salvianolic acid B exerts anti-hepatic fibrosis-carcinoma effect via mediation of pSmad3C/pSmad3L. Zhongguo Yaolixue Tongbao. 1:44–50. 2018.
17	Jiang W, Gao M, Sun S, Bi A, Xin Y, Han X, Wang L, Yin Z and Luo L: Protective effect of L-theanine on carbon tetrachloride-induced acute liver injury in mice. Biochem Biophys Res Commun. 422:344–350. 2012.PubMed/NCBI View Article : Google Scholar
18	Chu X, Wang H, Jiang YM, Zhang YY, Bao YF, Zhang X, Zhang JP, Guo H, Yang F, Luan YC, et al: Ameliorative effects of tannic acid on carbon tetrachloride-induced liver fibrosis in vivo and in vitro. J Pharmacol Sci. 130:15–23. 2016.PubMed/NCBI View Article : Google Scholar
19	El-Wakeel SA, Rahmo RM and El-Abhar HS: Anti-fibrotic impact of Carvedilol in a CCl-4 model of liver fibrosis via serum microRNA-200a/SMAD7 enhancement to bridle TGF-β1/EMT track. Sci Rep. 8(14327)2018.PubMed/NCBI View Article : Google Scholar
20	Al-Saeedi FJ: Study of the cytotoxicity of asiaticoside on rats and tumour cells. BMC Cancer. 14(220)2014.PubMed/NCBI View Article : Google Scholar
21	Hu X, Liang Y, Zhao B and Wang Y: Oxyresveratrol protects human lens epithelial cells against hydrogen peroxide-induced oxidative stress and apoptosis by activation of Akt/HO-1 pathway. J Pharmacol Sci. 139:166–173. 2019.PubMed/NCBI View Article : Google Scholar
22	Loboda A, Damulewicz M, Pyza E, Jozkowicz A and Dulak J: Role of Nrf2/HO-1 system in development, oxidative stress response and diseases: An evolutionarily conserved mechanism. Cell Mol Life Sci. 73:3221–3247. 2016.PubMed/NCBI View Article : Google Scholar
23	Morita M, Ishida N, Uchiyama K, Yamaguchi K, Itoh Y, Shichiri M, Yoshida Y, Hagihara Y, Naito Y, Yoshikawa T, et al: Fatty liver induced by free radicals and lipid peroxidation. Free Radic Res. 46:758–765. 2012.PubMed/NCBI View Article : Google Scholar
24	Patel SJ, Milwid JM, King KR, Bohr S, Iracheta-Vellve A, Li M, Vitalo A, Parekkadan B, Jindal R and Yarmush ML: Gap junction inhibition prevents drug-induced liver toxicity and fulminant hepatic failure. Nat Biotechnol. 30:179–183. 2012.PubMed/NCBI View Article : Google Scholar
25	Tsukamoto H, French SW, Benson N, Delgado G, Rao GA, Larkin EC and Largman C: Severe and progressive steatosis and focal necrosis in rat liver induced by continuous intragastric infusion of ethanol and low fat diet. Hepatology. 5:224–232. 1985.PubMed/NCBI View Article : Google Scholar
26	Schuppan D: Liver fibrosis: Common mechanisms and antifibrotic therapies. Clin Res Hepatol Gastroenterol. 39:51–59. 2015.PubMed/NCBI View Article : Google Scholar
27	Chen SR, Chen XP, Lu JJ, Wang Y and Wang YT: Potent natural products and herbal medicines for treating liver fibrosis. Chin Med. 10(7)2015.PubMed/NCBI View Article : Google Scholar
28	Stickel F and Schuppan D: Herbal medicine in the treatment of liver diseases. Dig Liver Dis. 39:293–304. 2007.PubMed/NCBI View Article : Google Scholar
29	Ma X, Peng JH and Hu YY: Chinese Herbal Medicine-induced liver injury. J Clin Transl Hepatol. 2:170–175. 2014.PubMed/NCBI View Article : Google Scholar
30	Rui W, Xie L, Liu X, He S, Wu C, Zhang X, Zhang L and Yang Y: Compound Astragalus and Salvia miltiorrhiza extract suppresses hepatocellular carcinoma progression by inhibiting fibrosis and PAI-1 mRNA transcription. J Ethnopharmacol. 151:198–209. 2014.PubMed/NCBI View Article : Google Scholar
31	Liu T, Xia Y, Li J, Li S, Feng J, Wu L, Zhang R, Xu S, Cheng K, Zhou Y, et al: Shikonin attenuates Concanavalin A-induced acute liver injury in mice via inhibition of the JNK pathway. Mediators Inflamm. 2016(2748367)2016.PubMed/NCBI View Article : Google Scholar
32	Clark JM, Brancati FL and Diehl AM: The prevalence and etiology of elevated aminotransferase levels in the United States. Am J Gastroenterol. 98:960–967. 2003.PubMed/NCBI View Article : Google Scholar
33	Anderson FH, Zeng L, Rock NR and Yoshida EM: An assessment of the clinical utility of serum ALT and AST in chronic hepatitis C. Hepatol Res. 18:63–71. 2000.PubMed/NCBI View Article : Google Scholar
34	Giannini E, Botta F, Fasoli A, Ceppa P, Risso D, Lantieri PB, Celle G and Testa R: Progressive liver functional impairment is associated with an increase in AST/ALT ratio. Dig Dis Sci. 44:1249–1253. 1999.PubMed/NCBI View Article : Google Scholar
35	Bhadauria M, Nirala SK, Shrivastava S, Sharma A, Johri S, Chandan BK, Singh B, Saxena AK and Shukla S: Emodin reverses CCl induced hepatic cytochrome P450 (CYP) enzymatic and ultrastructural changes: The in vivo evidence. Hepatol Res. 39:290–300. 2009.PubMed/NCBI View Article : Google Scholar
36	Comporti M: Three models of free radical-induced cell injury. Chem Biol Interact. 72:1–56. 1989.PubMed/NCBI View Article : Google Scholar
37	Sies H: Oxidative stress: A concept in redox biology and medicine. Redox Biol. 4:180–183. 2015.PubMed/NCBI View Article : Google Scholar
38	Kalpravidh RW, Siritanaratkul N, Insain P, Charoensakdi R, Panichkul N, Hatairaktham S, Srichairatanakool S, Phisalaphong C, Rachmilewitz E and Fucharoen S: Improvement in oxidative stress and antioxidant parameters in beta-thalassemia/Hb E patients treated with curcuminoids. Clin Biochem. 43:424–429. 2010.PubMed/NCBI View Article : Google Scholar
39	Liu RM and Desai LP: Reciprocal regulation of TGF-β and reactive oxygen species: A perverse cycle for fibrosis. Redox Biol. 6:565–577. 2015.PubMed/NCBI View Article : Google Scholar
40	Derynck R and Zhang YE: Smad-dependent and Smad-inde pendent pathways in TGF-beta family signalling. Nature. 425:577–584. 2003.PubMed/NCBI View Article : Google Scholar
41	Inagaki Y and Okazaki I: Emerging insights into transforming growth factor beta Smad signal in hepatic fibrogenesis. Gut. 56:284–292. 2007.PubMed/NCBI View Article : Google Scholar
42	Hu HH, Chen DQ, Wang YN, Feng YL, Cao G, Vaziri ND and Zhao YY: New insights into TGF-β/Smad signaling in tissue fibrosis. Chem Biol Interact. 292:76–83. 2018.PubMed/NCBI View Article : Google Scholar
43	Burch ML, Yang SNY, Ballinger ML, Getachew R, Osman N and Little PJ: TGF-beta stimulates biglycan synthesis via p38 and ERK phosphorylation of the linker region of Smad2. Cell Mol Life Sci. 67:2077–2090. 2010.PubMed/NCBI View Article : Google Scholar
44	Zhang H, Liu YY, Jiang Q, Li KR, Zhao YX, Cao C and Yao J: Salvianolic acid A protects RPE cells against oxidative stress through activation of Nrf2/HO-1 signaling. Free Radic Biol Med. 69:219–228. 2014.PubMed/NCBI View Article : Google Scholar
45	Oh CJ, Kim JY, Min AK, Park KG, Harris RA, Kim HJ and Lee IK: Sulforaphane attenuates hepatic fibrosis via NF-E2-related factor 2-mediated inhibition of transforming growth factor-β/Smad signaling. Free Radic Biol Med. 52:671–682. 2012.PubMed/NCBI View Article : Google Scholar
46	Chen Q, Zhang H, Cao Y, Li Y, Sun S, Zhang J and Zhang G: Schisandrin B attenuates CCl₄-induced liver fibrosis in rats by regulation of Nrf2-ARE and TGF-β/Smad signaling pathways. Drug Des Devel Ther. 11:2179–2191. 2017.PubMed/NCBI View Article : Google Scholar
47	Zhang X, Wu Q, Lu Y, Wan J, Dai H, Zhou X, Lv S, Chen X, Zhang X, Hang C, et al: Cerebroprotection by salvianolic acid B after experimental subarachnoid hemorrhage occurs via Nrf2- and SIRT1-dependent pathways. Free Radic Biol Med. 124:504–516. 2018.PubMed/NCBI View Article : Google Scholar
48	Liu M, Xu H, Zhang L, Zhang C, Yang L, Ma E, Liu L and Li Y: Salvianolic acid B inhibits myofibroblast transdifferentiation in experimental pulmonary fibrosis via the up-regulation of Nrf2. Biochem Biophys Res Commun. 495:325–331. 2018.PubMed/NCBI View Article : Google Scholar
49	Wang B, Sun J, Shi Y and Le G: Salvianolic acid B inhibits high-fat diet-induced inflammation by activating the Nrf2 pathway. J Food Sci. 82:1953–1960. 2017.PubMed/NCBI View Article : Google Scholar
50	Lu C, Xu W and Zheng S: Nrf2 activation is required for curcumin to induce lipocyte phenotype in hepatic stellate cells. Biomed Pharmacother. 95:1–10. 2017.PubMed/NCBI View Article : Google Scholar